In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Trauson Holdings Co. Ltd.

Division of Stryker Corp.
www.trauson.com

Latest From Trauson Holdings Co. Ltd.

Tough At The Top: Raj Denhoy On The Drive For Growth In A Maturing Medtech Industry

The medical technology industry was a solid if tricky bet for investors in 2017, and will be so in 2018. That is the view of Jefferies Healthcare US-based equity analyst Raj Denhoy. Speaking to In Vivo during the group's London meeting in fall 2017, he gave context to the motivations and drivers of medtechs large and small for 2018 and beyond.

M & A Strategy

Medtechs At The Wheel In New Health Care Landscape

2016 was a year of surprise and change in political circles, but that's nothing new for the medtech industry, which over a number of years has become accustomed to health care systems demanding different and ever-higher levels of service. Smart medtechs have been ahead of the curve, but the whole industry now factors in clients' wider needs in a holistic approach to patient care. Many companies' current M&A policies are already reflecting the changes to come.

M & A Deals

Timing, Returns Record Right For Vivo Capital Fundraising

Once a lesser known firm in US life sciences investing, Vivo Capital has emerged as a global leader in biopharmaceutical and medtech start-ups, raising a $750 million fund that will be invested in the US, Europe, and China.

Medical Device BioPharmaceutical

Commercial Model Innovation Critical To Win China: McKinsey

Despite a well-tailored product lineup targeting the value market segment being high on top medical device executives’ minds, a more sophisticated commercial model will help win the day in China. In effect, a key shift away from fast sales force expansion towards sophistication and specialization is emerging in the country, notes a new McKinsey study.

Medical Device China
See All

Company Information

  • Industry
  • Medical Devices
    • Implantable Devices
    • Surgical Equipment & Devices
  • Therapeutic Areas
  • Musculoskeletal & Connective Tissue Disorders
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Asia
      • China
  • Parent & Subsidiaries
  • Stryker Corp.
  • Senior Management
  • TzeChong Chiam, CFO
    Aiguo Wang, Chmn. & Gen. Mgr.
    Yong Cai, Dir., R&D
    Jia Kang Chen, Gen. Mgr., Sales & Mktg.
    De Sheng Cheng, COO
  • Contact Info
  • Trauson Holdings Co. Ltd.
    Phone: 519 8166 5318
    9 Longmen Road
    Wujin Ind. Zone
    Changzhou, 213164
    China
UsernamePublicRestriction

Register